EA200300572A1 - COMBINED THERAPY OF ESTROGEN-DEPENDENT DISEASES - Google Patents
COMBINED THERAPY OF ESTROGEN-DEPENDENT DISEASESInfo
- Publication number
- EA200300572A1 EA200300572A1 EA200300572A EA200300572A EA200300572A1 EA 200300572 A1 EA200300572 A1 EA 200300572A1 EA 200300572 A EA200300572 A EA 200300572A EA 200300572 A EA200300572 A EA 200300572A EA 200300572 A1 EA200300572 A1 EA 200300572A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- estrogen
- combined therapy
- dependent diseases
- dependent
- testicles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Настоящее изобретение касается комбинированной терапии эстроген-зависимых злокачественных опухолей у восприимчивых млекопитающих, включая человека, состоящей из этапов ингибирования гормональной продукции их яичек или яичников, соответственно, и введения указанному млекопитающему по меньшей мере одного ингибитора ароматазы.The present invention relates to a combination therapy of estrogen-dependent malignant tumors in susceptible mammals, including humans, consisting of the steps of inhibiting the hormonal production of their testicles or ovaries, respectively, and administering at least one aromatase inhibitor to said mammal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71460500A | 2000-11-16 | 2000-11-16 | |
PCT/US2001/043847 WO2002039995A2 (en) | 2000-11-16 | 2001-11-06 | Combination therapy for estrogen-dependent disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200300572A1 true EA200300572A1 (en) | 2004-06-24 |
Family
ID=24870727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200300572A EA200300572A1 (en) | 2000-11-16 | 2001-11-06 | COMBINED THERAPY OF ESTROGEN-DEPENDENT DISEASES |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1341549A2 (en) |
JP (1) | JP2004536022A (en) |
KR (1) | KR20030051828A (en) |
CN (1) | CN1498112A (en) |
AU (1) | AU2002230464A1 (en) |
BR (1) | BR0115423A (en) |
CA (1) | CA2428249A1 (en) |
CZ (1) | CZ20031349A3 (en) |
EA (1) | EA200300572A1 (en) |
IL (1) | IL155817A0 (en) |
MX (1) | MXPA03004195A (en) |
NO (1) | NO20032206L (en) |
NZ (1) | NZ525720A (en) |
PL (1) | PL365904A1 (en) |
WO (1) | WO2002039995A2 (en) |
ZA (1) | ZA200303669B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9050378B2 (en) | 2003-12-10 | 2015-06-09 | Board Of Regents, The University Of Texas System | N2S2 chelate-targeting ligand conjugates |
GB0506759D0 (en) * | 2005-04-02 | 2005-05-11 | Medical Res Council | Combination treatment methods |
EP1891964A1 (en) * | 2006-08-08 | 2008-02-27 | AEterna Zentaris GmbH | Application of initial doses of LHRH analogues and maintenance doses of LHRH antagonists for the treatment of hormone-dependent cancers and corresponding pharmaceutical kits |
US10925977B2 (en) | 2006-10-05 | 2021-02-23 | Ceil>Point, LLC | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
CA2683517A1 (en) * | 2007-04-23 | 2008-10-30 | Bayer Schering Pharma Aktiengesellschaft | Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseases |
CN101775054B (en) * | 2010-02-05 | 2012-12-26 | 常州佳尔科药业集团有限公司 | Synthesis method of 4-hydroxyl-4-alkene-3-ketone steroide compound |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9911582D0 (en) * | 1999-05-18 | 1999-07-21 | Pharmacia & Upjohn Spa | Combined method of treatment comprising an aromatase inhibitor and a further biologically active compound |
GB9930839D0 (en) * | 1999-12-30 | 2000-02-16 | Pharmacia & Upjohn Spa | Process for treating gynecomastia |
-
2001
- 2001-11-06 BR BR0115423-0A patent/BR0115423A/en not_active IP Right Cessation
- 2001-11-06 PL PL01365904A patent/PL365904A1/en not_active Application Discontinuation
- 2001-11-06 IL IL15581701A patent/IL155817A0/en unknown
- 2001-11-06 EP EP01990699A patent/EP1341549A2/en not_active Withdrawn
- 2001-11-06 CA CA002428249A patent/CA2428249A1/en not_active Abandoned
- 2001-11-06 MX MXPA03004195A patent/MXPA03004195A/en unknown
- 2001-11-06 JP JP2002542370A patent/JP2004536022A/en active Pending
- 2001-11-06 EA EA200300572A patent/EA200300572A1/en unknown
- 2001-11-06 CN CNA018189385A patent/CN1498112A/en active Pending
- 2001-11-06 NZ NZ525720A patent/NZ525720A/en unknown
- 2001-11-06 CZ CZ20031349A patent/CZ20031349A3/en unknown
- 2001-11-06 AU AU2002230464A patent/AU2002230464A1/en not_active Abandoned
- 2001-11-06 WO PCT/US2001/043847 patent/WO2002039995A2/en active Application Filing
- 2001-11-06 KR KR10-2003-7006608A patent/KR20030051828A/en not_active Application Discontinuation
-
2003
- 2003-05-13 ZA ZA200303669A patent/ZA200303669B/en unknown
- 2003-05-15 NO NO20032206A patent/NO20032206L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2004536022A (en) | 2004-12-02 |
WO2002039995A9 (en) | 2003-02-06 |
NO20032206L (en) | 2003-07-15 |
CZ20031349A3 (en) | 2004-05-12 |
ZA200303669B (en) | 2004-05-13 |
WO2002039995A2 (en) | 2002-05-23 |
KR20030051828A (en) | 2003-06-25 |
AU2002230464A1 (en) | 2002-05-27 |
IL155817A0 (en) | 2003-12-23 |
NZ525720A (en) | 2006-12-22 |
CN1498112A (en) | 2004-05-19 |
NO20032206D0 (en) | 2003-05-15 |
WO2002039995A3 (en) | 2003-05-01 |
PL365904A1 (en) | 2005-01-10 |
BR0115423A (en) | 2005-12-13 |
EP1341549A2 (en) | 2003-09-10 |
MXPA03004195A (en) | 2003-09-22 |
CA2428249A1 (en) | 2002-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE324444T1 (en) | TEK ANTAGONISTS | |
MXPA03002778A (en) | ANTIANGIOGEN POLYPEPTIDES AND METHODS TO INHIBIT ANGIOGENESIS. | |
BRPI0207961A8 (en) | USE OF EPOTHYLONE AND CAPECITABIN ANALOGS TO MANUFACTURE DRUG TO TREAT SOLID CANCEROUS TUMORS AND KIT COMPRISING THE SAID COMPOUNDS. | |
MY137766A (en) | Exemestane as chemopreventing agent | |
UY26815A1 (en) | METHODS FOR TREATING Rheumatic Diseases When Using a CTLA4 SOLUBLE MOLECULE | |
DE60231439D1 (en) | MITOTIC KINESINE HEMMER | |
DE60234278D1 (en) | MITOTIC KINESINE HEMMER | |
HN2001000244A (en) | SPIROPIRIMIDIN INHIBITORS - 2, 4, 6 - TRIONA METALOPROTEINASAS. | |
ATE303156T1 (en) | USE OF GNRH ANALOGUE TO TREAT URINARY INCONTINENCE | |
SE9800836D0 (en) | New Compounds | |
EA200800755A1 (en) | IKK INHIBITORS INTRODUCED FOR THE TREATMENT OF ENDOMETRIOSIS | |
UA90698C2 (en) | Triazole substituted aminobenzophenone compounds | |
TR200101895T2 (en) | Treatment of sexual ailments. | |
TR200101120T2 (en) | Serine protease inhibitor | |
PT1390371E (en) | OXAZOLO- AND FUROPYRIMIDINES AND THEIR USE IN MEDICINES AGAINST TUMORS | |
EA200500244A1 (en) | TETRAPROPILAMMONIA TETRATIOMOLYBDAT AND RELATED COMPOUNDS FOR ANTIANGIOGENIC THERAPY | |
TR200003443T2 (en) | Combination therapy for the treatment of impressive depression | |
EA200201276A1 (en) | ARYLMETYLAMINE DERIVATIVES FOR USE AS TRIPTASE INHIBITORS | |
ES2163795T3 (en) | PHARMACEUTICAL COMPOSITION AGAINST TUMORS AND INFECTIONS BY PAPILOMAVIRUS. | |
ATE412412T1 (en) | DERIVATIVES OF 3-HYDROXY-4-(CYCLYL-ALKYLAMINOALKYL)-5-PHENYL-1-PYRAZOLE AS ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE (GNRH) FOR USE IN THE TREATMENT OF SEX HORMONAL DISEASES, SUCH AS PROSTATE OR MATERNAL CANCER | |
EA200300572A1 (en) | COMBINED THERAPY OF ESTROGEN-DEPENDENT DISEASES | |
BR0114430A (en) | Processes for cancer cell death induction and tumor regression | |
ATE489103T1 (en) | TARGETED THROMBOSIS THROUGH TISSUE FACTOR POLYPEPTIDES | |
PA8453601A1 (en) | FARNESIL TRANSFERASE INHIBITORS COMBINED WITH HMG COA REDUCTASE INHIBITORS FOR CANCER TREATMENT | |
TR200101693T2 (en) | Treatment of follicular lymphomas using inhibitors of the lysophoxin (LT) expression pathway. |